It is sometimes easy to see these Dr’s names up on stage that talk about us and think nothing off it. However, we often do not realise how important these Drs are and have been in the history of TAVR.
As example, if you read below you will learn that Professor Eberhard Grube did the first human CoreValve implantation in Europe in 2005. It’s amazing to have these highly acclaimed and historically important Drs up on stage explaining our AVR DurAVR results.
”A new self-expandable biological valve (CoreValve) was pioneered by the French cardiac surgeon Professor Jacques Seguin. Following initial implants in patients in India in 2002 (16), the first human implantation in Europe was performed by Professor Eberhard Grube in Germany in 2005 (17), followed by a registry study in 25 patients (18). These procedures were performed with the patient in general anesthesia and with percutaneous extracorporeal femoral-femoral bypass.”
AVR Price at posting:
$22.37 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)